In view of the importance of regulatory matters regarding worldwide drug development, product & licence maintenance and the harmonisation of the European Drug Law within the EU-member States FOCUS Clinical Drug Development, a renowned European Clinical CRO, has established FOCUS Regulatory Affairs Ltd. in 2004.

We are convinced that our international pharma and biotech clients will benefit from this additional know-how be it for drug development strategy, early registration and product maintenance or for specific advice on the management of the clinical trials applications process in Germany or other EU-member states.

Our competence and experience as well as our regular contacts with regulatory authorities (EMEA, BfArM, etc) will proactively move your projects forward.